AbbVie Noncontrolling interest transactions and other decreased by 94.6% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 97.0%, from $67.00M to $2.00M.
lin_noncontrolling_interest_transactions_and_other| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.00M | $21.00M | $2.00M | $21.00M | $5.00M | $15.00M | $21.00M | $30.00M | $24.00M | $0.00 | $32.00M | $1.00M | $67.00M | $37.00M | $2.00M |
| QoQ Change | — | +320.0% | -90.5% | +950.0% | -76.2% | +200.0% | +40.0% | +42.9% | -20.0% | -100.0% | — | -96.9% | >999% | -44.8% | -94.6% |
| YoY Change | — | — | — | — | +0.0% | -28.6% | +0.0% | +100.0% | +14.3% | — | +6.7% | — | +179.2% | +15.6% | -97.0% |